Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer.
Otani K, Aoyama T, Maezawa Y, Hashimoto I, Kamiya N, Kato A, Numata M, Kawahara S, Tamagawa A, Nakazono M, Tamagawa H, Segami K, Kazama K, Sawazaki S, Yukawa N, Saito A, Rino Y. Otani K, et al. Among authors: hashimoto i. In Vivo. 2024 Mar-Apr;38(2):897-903. doi: 10.21873/invivo.13516. In Vivo. 2024. PMID: 38418135 Free PMC article.
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
Maezawa Y, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Kano K, Aoyama T, Hiroshima Y, Yamada T, Yamamoto N, Ogata T, Ito H, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Maezawa Y, et al. Among authors: hashimoto i. J Cancer Res Clin Oncol. 2020 Jan;146(1):75-86. doi: 10.1007/s00432-019-03087-8. Epub 2019 Nov 21. J Cancer Res Clin Oncol. 2020. PMID: 31754833 Free PMC article.
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy.
Oneyama M, Sakamoto N, Oue N, Kimura Y, Hiroshima Y, Hashimoto I, Hara K, Maezawa Y, Kano K, Aoyama T, Fujikawa H, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Yukawa N, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Miyagi Y, Yasui W, Oshima T. Oneyama M, et al. Among authors: hashimoto i. Anticancer Res. 2019 Dec;39(12):6567-6573. doi: 10.21873/anticanres.13872. Anticancer Res. 2019. PMID: 31810922
Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy.
Kano K, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Maezawa Y, Aoyama T, Fujikawa H, Hiroshima Y, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Kano K, et al. Among authors: hashimoto i. In Vivo. 2020 Jan-Feb;34(1):461-467. doi: 10.21873/invivo.11796. In Vivo. 2020. PMID: 31882514 Free PMC article.
The Impact of Intraoperative Blood Loss on the Long-term Prognosis after Curative Resection for Borrmann Type IV Gastric Cancer: A Retrospective Multicenter Study.
Tamagawa H, Aoyama T, Kano K, Numata M, Atsumi Y, Hara K, Kazama K, Koumori K, Murakawa M, Hashimoto I, Maezawa Y, Yamada T, Yukawa N, Yoshikawa T, Masuda M, Oshima T, Rino Y. Tamagawa H, et al. Among authors: hashimoto i. Anticancer Res. 2020 Jan;40(1):405-412. doi: 10.21873/anticanres.13967. Anticancer Res. 2020. PMID: 31892594
917 results